These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12176467)

  • 1. Steroid withdrawal under tacrolimus for primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term survival.
    Jain A; Pokharna R; Eghtesad B; Potdar S; Kashyap R; Kingery L; Fung J
    Transplant Proc; 2002 Aug; 34(5):1524-5. PubMed ID: 12176467
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.
    Duclos-Vallee JC; Sebagh M
    Liver Transpl; 2009 Nov; 15 Suppl 2():S25-34. PubMed ID: 19876939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation.
    Duclos-Vallée JC
    Acta Gastroenterol Belg; 2005; 68(3):331-6. PubMed ID: 16268420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in autoimmune liver diseases.
    Ilyas JA; O'Mahony CA; Vierling JM
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):765-82. PubMed ID: 22117641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of liver transplantation in autoimmune liver diseases.
    Zhong CP; Xi ZF; Xia Q
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):27-31. PubMed ID: 29428100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
    Chai PF; Lee WS; Brown RM; McPartland JL; Foster K; McKiernan PJ; Kelly DA
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):295-302. PubMed ID: 20118802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy.
    Jonas S; Guckelberger O; Tullius SG; Steinmüller T; Müller AR; Grauhan O; Langrehr JM; Bechstein WO; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2232-3. PubMed ID: 11377511
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver transplantation and autoimmunity.
    Jaeckel E; Tillmann HL; Manns MP
    Acta Gastroenterol Belg; 1999; 62(3):323-9. PubMed ID: 10547899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Balan V; Ruppert K; Demetris AJ; Ledneva T; Duquesnoy RJ; Detre KM; Wei YL; Rakela J; Schafer DF; Roberts JP; Everhart JE; Wiesner RH
    Hepatology; 2008 Sep; 48(3):878-88. PubMed ID: 18752327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in autoimmune liver disease--selection of patients.
    Tillmann HL; Jäckel E; Manns MP
    Hepatogastroenterology; 1999; 46(30):3053-9. PubMed ID: 10626159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of autoimmune and cholestatic liver disorders.
    Krok KL; Munoz SJ
    Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation in autoimmune liver diseases.
    Mottershead M; Neuberger J
    World J Gastroenterol; 2008 Jun; 14(21):3388-95. PubMed ID: 18528936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.
    Patel YA; Henson JB; Wilder JM; Zheng J; Chow SC; Berg CL; Knechtle SJ; Muir AJ
    Clin Transplant; 2018 Oct; 32(10):e13388. PubMed ID: 30136315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
    Faust TW
    Semin Liver Dis; 2000; 20(4):481-95. PubMed ID: 11200417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune liver disease, autoimmunity and liver transplantation.
    Carbone M; Neuberger JM
    J Hepatol; 2014 Jan; 60(1):210-23. PubMed ID: 24084655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal.
    Campsen J; Zimmerman M; Trotter J; Wachs M; Bak T; Steinberg T; Kaplan M; Kam I
    Transplant Proc; 2009 Jun; 41(5):1707-12. PubMed ID: 19545712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.
    Tanaka A; Kono H; Leung PSC; Gershwin ME
    Cell Immunol; 2020 Jan; 347():104021. PubMed ID: 31767117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis.
    McEntee G; Wiesner RH; Rosen C; Cooper J; Wahlstrom E
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1563-4. PubMed ID: 1989291
    [No Abstract]   [Full Text] [Related]  

  • 20. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
    Ringe B; Braun F; Wietzke P; Oellerich M; Ramadori G
    Transplant Proc; 2000 Nov; 32(7):2543. PubMed ID: 11120285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.